Jourdeness Group Ltd. (4190.TW)
Taichung, TW
Jourdeness Group Limited, together with its subsidiaries, manufactures and sells cosmetics in China, Taiwan, and internationally. The company also engages in the beauty and body spa business; and operation of a tourist factory, as well as offers consulting services of beauty and body spa business and equipment rental services. In addition, it provides investment and management consulting services. The company was founded in 1989 and is based in Taichung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.20% | -5.53% | -15.09% | -18.59% | -17.09% | -33.11% | -69.82% | -67.77% | -72.00% | -79.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-12 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+1.3% Q1'26: -8.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+67.4% ★ Q1'26: +43.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+18.3% ★ Q1'26: +15.2% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%-1.6% Q1'26: -0.7% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%-1.1% Q1'26: -0.5% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-1.2% ★ Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×4.58× Q1'26: 4.82× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.74B
est: 1.73B (+0.2%)
|
1.83B
est: 1.84B (0.0%)
|
2.31B
est: 2.31B (0.0%)
|
3.11B
est: 3.11B (0.0%)
|
3.25B
est: 3.24B (+0.4%)
|
2.73B
est: 2.77B (-1.3%)
|
2.82B
est: 2.76B (+2.1%)
|
2.78B
est: 2.78B (+0.0%)
|
2.98B
est: 2.52B (+18.2%)
|
2.28B
est: 2.44B (-6.5%)
|
2.31B
est: 2.31B (+0.0%)
|
| EBITDA |
551.58M
est: 563.34M (-2.1%)
|
469.47M
est: 596.26M (-21.3%)
|
462.26M
est: 751.90M (-38.5%)
|
997.54M
est: 1.01B (-1.2%)
|
1.41B
est: 1.05B (+33.8%)
|
1.10B
est: 898.94M (+22.2%)
|
1.14B
est: 897.48M (+26.8%)
|
802.49M
est: 902.67M (-11.1%)
|
878.67M
est: 749.76M (+17.2%)
|
535.32M
est: 726.61M (-26.3%)
|
615.39M
est: 687.73M (-10.5%)
|
| EBIT |
426.01M
est: 104.04M (+309.5%)
|
328.52M
est: 110.12M (+198.3%)
|
218.47M
est: 138.86M (+57.3%)
|
700.69M
est: 186.56M (+275.6%)
|
692.04M
est: 194.37M (+256.0%)
|
396.92M
est: 166.02M (+139.1%)
|
438.74M
est: 165.75M (+164.7%)
|
106.94M
est: 166.71M (-35.9%)
|
106.51M
est: 63.69M (+67.2%)
|
-198.92M
est: 61.72M (-422.3%)
|
-37.40M
est: 58.42M (-164.0%)
|
| Net Income |
341.91M
est: 379.77M (-10.0%)
|
272.23M
est: 272.72M (-0.2%)
|
182.40M
est: 169.25M (+7.8%)
|
527.53M
est: 515.30M (+2.4%)
|
470.47M
est: 460.90M (+2.1%)
|
257.73M
est: 268.98M (-4.2%)
|
292.16M
est: 374.04M (-21.9%)
|
13.98M
est: 104.95M (-86.7%)
|
-258.0K
|
-291.95M
est: 1.19M (-24,722.7%)
|
-94.26M
est: 219.94M (-142.9%)
|
| SGA |
734.34M
est: 1.11B (-34.1%)
|
902.15M
est: 1.18B (-23.5%)
|
1.39B
est: 1.49B (-6.5%)
|
1.66B
est: 2.00B (-17.0%)
|
1.77B
est: 2.08B (-14.8%)
|
1.65B
est: 1.78B (-7.3%)
|
1.70B
est: 1.77B (-4.3%)
|
1.80B
est: 1.78B (+0.9%)
|
1.92B
est: 1.64B (+17.0%)
|
1.63B
est: 1.59B (+2.3%)
|
1.50B
est: 1.51B (-0.2%)
|
| EPS |
6.45
est: 6.33 (+1.9%)
|
4.66
est: 4.55 (+2.5%)
|
3.12
est: 2.82 (+10.6%)
|
9.02
est: 8.59 (+5.0%)
|
8.05
est: 7.69 (+4.7%)
|
4.41
est: 4.49 (-1.7%)
|
4.98
est: 6.24 (-20.1%)
|
0.24
est: 1.75 (-86.3%)
|
0.00
|
-4.87
est: 0.02 (-24,450.0%)
|
-1.59
est: 3.71 (-142.9%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Value ETF AVES | 0.00% | 5.6K | 0.36% |
| 2 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 36.0K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheng-Hsiung Chen | Chairman & Chief Strategy Officer | 6M | male |
| Chia-Chi Chen | Chief Operating Officer, GM & Director | 3M | female |
| Hsiao-Hui Cheng | Chief Financial Officer & Accounting Supervisor | 2M | female |
| Yu-Chien Chen | Chief Administration Officer | 2M | female |
| Li-Ping Lu | Chief R&D Officer of the Group | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4190.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
